180 Life Sciences Corp (ATNF)
1.585
-0.06
(-3.94%)
USD |
NASDAQ |
May 17, 16:00
1.585
0.00 (0.00%)
After-Hours: 20:00
180 Life Sciences Cash from Operations (Quarterly): -2.16M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.16M |
| September 30, 2023 | -1.776M |
| June 30, 2023 | -3.117M |
| March 31, 2023 | -3.870M |
| December 31, 2022 | -2.927M |
| September 30, 2022 | -3.596M |
| June 30, 2022 | -3.532M |
| March 31, 2022 | -2.073M |
| Date | Value |
|---|---|
| December 31, 2021 | -5.028M |
| September 30, 2021 | -4.003M |
| June 30, 2021 | -4.011M |
| March 31, 2021 | -6.33M |
| December 31, 2020 | -3.216M |
| September 30, 2020 | -0.054M |
| June 30, 2020 | -0.1926M |
| March 31, 2020 | -0.409M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-6.33M
Minimum
Mar 2021
-0.054M
Maximum
Sep 2020
-2.893M
Average
-3.167M
Median
Cash from Operations (Quarterly) Benchmarks
| Seelos Therapeutics Inc | -1.911M |
| Altimmune Inc | -16.36M |
| GT Biopharma Inc | -2.047M |
| Outlook Therapeutics Inc | -13.03M |
| MAIA Biotechnology Inc | -3.992M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 1.468M |
| Free Cash Flow | -10.92M |
| Free Cash Flow Per Share (Quarterly) | -4.040 |
| Free Cash Flow Yield | -1.93K% |